Trial Profile
Phase I single ascending dose trial of FAB 001 in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Jul 2017
Price :
$35
*
At a glance
- Drugs FAB 001 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 05 Jun 2017 Results presented at the ASM Microbe 2017
- 03 Oct 2012 New trial record
- 07 May 2011 Trial results reported at the 21st European Congress of Clinical Microbiology and Infectious Diseases and the 27th International Congress of Chemotherapy